291 related articles for article (PubMed ID: 7013458)
1. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
[TBL] [Abstract][Full Text] [Related]
3. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
4. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
5. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
6. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
Creager MA; Halperin JL; Bernard DB; Faxon DP; Melidossian CD; Gavras H; Ryan TJ
Circulation; 1981 Sep; 64(3):483-9. PubMed ID: 6266691
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
8. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
9. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
10. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
11. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
15. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
16. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
17. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
19. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
